Using Trademarks to Ensure Completion of Postapproval Trials
Year: 2025
Type: article
Abstract: This Viewpoint evaluates how using trademarks can support the US Food and Drug Administration’s mission to approve safe and effective medications.
Source: JAMA Health Forum
Authors: Catherine S. Hwang, S. Sean Tu
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: gold
Estimated APC paid: $5,000
OpenAlex ID: W4408052194
